Related Experiment Videos
IgE bullous disease
N Y Talanin1, W B Shelley, E D Shelley
1Department of Medicine, Medical College of Ohio, Toledo 43699, USA.
Clinical and Experimental Dermatology
|March 1, 1997
Summary
This study describes two bullous pemphigoid patients lacking typical IgG/C3 markers but showing IgE deposition. This suggests a rare
Area of Science:
- Immunodermatology
- Allergy and Immunology
- Pathology
Background:
- Bullous pemphigoid (BP) is an autoimmune blistering disease typically characterized by IgG or C3 deposition at the epidermal basement membrane zone (BMZ).
- Diagnostic criteria for BP usually include circulating IgG autoantibodies against BMZ components.
Observation:
- Two patients presented with clinical features of bullous pemphigoid but lacked the characteristic IgG/C3 deposition and circulating IgG antibodies.
- These patients exhibited dense eosinophil infiltrates in skin lesions and significantly elevated serum IgE levels.
- Immunofluorescence revealed IgE deposition on dermal inflammatory cells, identified as eosinophils via major basic protein (MBP) staining.
Findings:
- The findings suggest a distinct subtype of bullous disease, potentially an 'IgE bullous disease', mediated by IgE hypersensitivity.
- Initial response to antibiotics in both patients points towards a possible role of focal infection in disease induction.
- Surgical interventions, including device removal and amputation, led to dramatic resolution of bullae, indicating a link to underlying pathology.
Implications:
- This case series expands the understanding of autoimmune blistering diseases, highlighting IgE-mediated mechanisms as a potential driver.
- The results suggest that alternative diagnostic and therapeutic strategies may be warranted for patients presenting with atypical immunopathology.
- Further research into IgE-mediated hypersensitivity in blistering disorders could reveal novel treatment targets.